Most Recent
Merger to create $285M IP firm poised for Asia push
Baker McKenzie 2018-11-27 11:02 pm By Cat Fredenburgh

The companies that own some of Australia’s largest intellectual property boutiques have agreed to a merger that will create a 349 employee-strong firm that’s a force to be reckoned with in the market for IP services in Asia Pacific.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Elle publisher wins opposition to Aussie builder’s ‘Ella’ trade mark
Consumer Goods 2018-11-27 1:28 pm By Christine Caulfield Melbourne

The Paris-based publisher of Elle Magazine has succeeded in a challenge to a trade mark application by an Australian building supplier for the name of its brand of bathroom fixtures, ‘Ella’.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Dr Reddy’s settles Millennium’s cancer drug patent suit
Biopharmalex 2018-09-18 1:54 pm By Miklos Bolza Sydney

Generic drug maker Dr Reddy’s Laboratories has reached a settlement with US-based Millennium Pharmaceuticals, agreeing to be restrained from selling a cheap version of cancer drug Velcade in Australia.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Mars melts Kraft’s patent for heat-resistant chocolate
Food and Beverage 2018-09-13 10:25 pm By Cat Fredenburgh Melbourne

Confectionery giant Mars has successfully opposed an application by Kraft Foods for an Australian patent for chocolate that doesn’t melt in the summer months.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Inhibox maker used Allergan’s Botox trade mark for comparison’s sake, court hears
Griffith Hack 2018-09-05 8:30 pm By Miklos Bolza Sydney

The company that manufactures Botox alternatives has denied infringing on Allergan’s Botox trade mark, telling a court Wednesday its use of the word was for comparative purposes only.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Millennium wins injunction against Juno over generic cancer drug
Biopharmalex 2018-08-27 11:27 am By Christine Caulfield Melbourne

US-based Millennium Pharmaceuticals has secured a temporary injunction that bans generic drug maker Juno Pharmaceuticals from importing or selling its cheap version of breakthrough cancer drug Velcade in Australia.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Dr. Reddy’s slams Millennium’s injunction bid in cancer drug case
Biopharmalex 2018-08-23 5:41 pm By Miklos Bolza Sydney

An urgent injunction sought by US-based Millennium Pharmaceuticals to block generic drug maker Dr Reddy’s Laboratories from launching a cheap version of the breakthrough cancer drug Velcade has been panned as unnecessary.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Patent suits launched over breakthrough cancer drug
Biopharmalex 2018-08-15 10:25 pm By Miklos Bolza Sydney

Two patent infringement lawsuits have been launched over attempts to sell generic versions of breakthrough cancer drug Velcade in Australia, after a US court last year struck down attempts to invalidate a patent for the drug.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Aristocrat fights ruling dismissing its patents as ‘game rules’
Appeals 2018-07-31 10:41 am By Cat Fredenburgh Melbourne

Aristocrat Technologies is pushing on with its bid for four innovation gaming patents, after a delegate for IP Australia revoked the patents because they amounted to nothing more than ‘games and game rules’.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

IP Australia revokes four Aristocrat Technologies gaming patents
Griffith Hack 2018-07-06 12:41 pm By Cat Fredenburgh Melbourne

IP Australia has revoked four innovation gaming patents held by Aristocrat Technologies related to the use of configurable symbols in a game, saying the inventions didn’t amount to anything other than games and game rules.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?